论文部分内容阅读
16例均系成年人,男12例,女4例.入院前咯血量在300ml 以上者11例,100～300ml 者5例。应用阿托品皮下注射量为每次0.5～1mg,用药总量最小者0.5mg,最大者4mg。用药1次者11例,3次者3例,4次者1例,用药次数最多者7次/3天1例,用药后咯血立即停止者11例,24小时内停止者2例,48小时内停止者2例,72小时内停止者1例。重复用药的病例均于第一次用药后咯血量明显减少,用药后仅1例继续咯血近200ml(入院前咯血400ml),余均在100ml 以下。有2例曾同时合用垂体后叶素静
16 cases were all adults, 12 males and 4 females, 11 cases had hemoptysis before admission, 300 cases had 100ml and 5 cases had 100 ~ 300ml. Application of atropine subcutaneous injection of 0.5 ~ 1mg each time, the smallest total amount of 0.5mg, the largest 4mg. 1 case was treated once in 1 case, 3 cases in 3 cases, 4 cases in 1 case, the most frequent medication in 7 cases / 3 days in 1 case, medication stopped immediately after hemoptysis in 11 cases, 24 hours stopped in 2 cases, 48 hours 2 cases of internal stops, stop within 72 hours in 1 case. Repeated medication in patients with hemoptysis were significantly reduced after the first medication, medication, only 1 case continue to hemoptysis nearly 200ml (admission hemoptysis 400ml), the remaining 100ml or less. 2 cases have combined pituitrin